Article
Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes.
Journal of molecular and cellular cardiology - 1 Jun 2018
Ceholski Delaine K, Turnbull Irene C, Kong Chi-Wing, Koplev Simon, Mayourian Joshua, Gorski Przemek A, Stillitano Francesca, Skodras Angelos A, Nonnenmacher Mathieu, Cohen Ninette, Björkegren Johan L M, Stroik Daniel R, Cornea Razvan L, Thomas David D, Li Ronald A, Costa Kevin D, Hajjar Roger J
Abstract excerpt
Dilated cardiomyopathy (DCM) can be caused by mutations in the cardiac protein phospholamban (PLN). We used CRISPR/Cas9 to insert the R9C PLN mutation at its endogenous locus into a human induced pluripotent stem cell (hiPSC) line from an individual with no cardiovascular disease. R9C PLN hiPSC-CMs display a blunted β-agonist response and defective calcium handling. In 3D human engineered cardiac tissues (hECTs),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
